Relay Therapeutics Inc. Common Stock vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.82B), while Direxion Daily Semiconductor Bear 3X Shares trades at $32.09 (market cap $1.89B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 2× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Direxion Daily Semiconductor Bear 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| RLAY | SOXS | |
|---|---|---|
Market Cap | $3.82B | $1.89B |
Volume | 4,332,079 | 66,118,733 |
Sector | Health | Leveraged / Inverse |
52-Week High | $20.75 | $988.00 |
52-Week Low | $6.03 | $29.62 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $2.93B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $30.645, up 3.43% today, reflecting its inverse leveraged exposure to semiconductor stocks. The technical outlook is bearish, with moving averages signaling strong selling pressure, while oscillators are neutral. Recent news highlights the fund's volatility and tactical use during semiconductor sector weakness, as seen in July 2026 when it surged on chip stock declines. A 1:10 stock split occurred on July 15, 2026, adjusting share structure.
The outlook for SOXS remains highly speculative, suited only for short-term traders betting against semiconductors. Key risks include the fund's decay from daily rebalancing, reliance on sector volatility, and persistent AI demand supporting chip stocks. Investors should avoid long-term holdings due to structural erosion and elevated loss potential in rising markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →